Return on Tangible Equity (Annual)

Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity

Pomdoctor Limited - Sponsored ADR (POM) had Return on Tangible Equity of 27.20% for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$57.19M
Net Income	$-30.40M
Cost of Goods Sold	$49.71M
Gross Profit	$7.48M
Operating Expenses	$74.15M
Operating Income	$-16.96M
Non-Operating Income/Expense	$-1.76M
Pre-Tax Income	$-18.72M
Normalized Pre-Tax Income	$-18.72M
Income after Taxes	$-18.72M
Income from Continuous Operations	$-18.72M
Consolidated Net Income/Loss	$-18.72M
Normalized Income after Taxes	$-18.72M
EBIT	$-16.96M
EBITDA	$-16.94M
Weighted-Average Shares Outstanding (Basic)	3.22M
Weighted-Average Shares Outstanding (Diluted)	3.22M
Earnings per Share (EPS) (Basic)	$-9.43
Earnings per Share (EPS) (Diluted)	$-9.43
Balance Sheet Financials
Current Assets	$15.01M
Property, Plant, and Equipment	$0.18M
Long-Term Assets	$0.37M
Total Assets	$15.38M
Current Liabilities	$31.20M
Long-Term Debt	$52.82M
Long-Term Liabilities	$53.01M
Total Liabilities	$84.20M
Common Equity	$-68.82M
Tangible Shareholders Equity	$-68.82M
Shareholders Equity	$-68.82M
Common Shares Outstanding	7.72M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-21.23M
Cash Flow from Investing Activities	$-0.23M
Cash Flow from Financial Activities	$22.01M
Beginning Cash	$1.09M
End Cash	$1.37M
Increase/Decrease in Cash	$0.28M
Stock-Based Compensation	$2.35M
Common Stock Dividends Paid	$23.44M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.48
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	-3.30
Debt to Equity Ratio	-0.94
Gross Margin	13.07%
Operating Margin	-29.66%
EBIT Margin	-29.66%
EBITDA Margin	-29.63%
Pre-Tax Profit Margin	-32.74%
Profit Margin	-53.16%
Free Cash Flow	$-21.38M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	3.72
Inventory Turnover	41.98
Receiveable Turnover	4.63
Days Sales in Receivables	78.88
Return on Equity	27.20%
Return on Tangible Equity	27.20%
Return on Assets	-121.73%
Return on Investments	117.00%
Book Value Per Share	$-8.92
Free Cash Flow per Share	$-6.63
Operating Cash Flow per Share	$-6.59

Data from Zacks Investment Research, Inc.